XOMAO
XOMA Corporation NASDAQ Listed Apr 12, 2021$25.34
+0.32%
vs $25.26
Mkt Cap $455.7M
52w Low $25.12
19.5% of range
52w High $26.25
50d MA $25.46
200d MA $25.43
P/E (TTM)
17.4x
EV/EBITDA
34.1x
P/B
4.4x
Debt/Equity
1.3x
ROE
37.8%
P/FCF
158.7x
RSI (14)
59.60
ATR (14)
$0.07
Beta
0.68
50d MA
$25.46
200d MA
$25.43
Avg Volume
6.5K
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
2200 Powell Street · EmeryVille, CA 94608 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | AMC | -0.11 | 0.26 | +327.0% | 25.44 | -0.7% | -0.4% | -0.0% | +0.3% | +0.0% | +0.0% | — |
| Nov 12, 2025 | AMC | -0.04 | 0.78 | +2037.5% | 25.44 | +0.2% | -0.0% | +0.3% | -0.5% | +0.1% | +0.3% | — |
| Aug 15, 2025 | AMC | -0.15 | 0.52 | +444.7% | 25.45 | -0.1% | -0.1% | -0.2% | -0.2% | +1.0% | -0.7% | — |
| May 13, 2025 | AMC | -0.24 | 0.20 | +183.2% | 25.04 | +0.0% | +0.0% | -0.0% | +0.1% | +1.0% | -0.2% | — |
| Mar 17, 2025 | AMC | -0.29 | -0.33 | -16.5% | 25.41 | -0.3% | -0.4% | -0.2% | +0.8% | -0.1% | +0.0% | — |
| Nov 7, 2024 | AMC | — | -1.47 | — | 25.55 | -0.1% | +0.2% | +0.0% | -0.2% | +0.1% | -0.2% | — |
| Aug 13, 2024 | AMC | — | 0.92 | — | 25.15 | -1.0% | +0.0% | -0.6% | -0.1% | +0.5% | +0.3% | — |
| May 9, 2024 | AMC | — | -0.74 | — | 25.12 | -0.1% | -0.1% | +0.6% | -0.4% | +0.4% | -0.6% | — |
| Mar 8, 2024 | AMC | — | -1.75 | — | 24.86 | -0.0% | +0.5% | +0.0% | -0.2% | +0.3% | +0.3% | — |
| Mar 6, 2024 | AMC | — | -0.48 | — | 24.50 | +0.4% | +1.0% | +0.4% | +0.5% | +0.0% | -0.2% | — |
| Aug 8, 2023 | AMC | — | -0.47 | — | 23.77 | +0.1% | +1.8% | +0.0% | -0.2% | +0.2% | +0.0% | — |
| May 9, 2023 | AMC | — | -1.55 | — | 23.21 | -0.5% | -0.5% | -1.3% | +2.6% | -2.1% | +0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.37 | $23.44 | +0.3% | +1.4% | -0.4% | +1.3% | +1.1% | -0.1% |
| Aug 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.94 | $23.97 | +0.1% | -0.7% | +1.8% | +0.0% | -0.2% | +0.2% |
| Jun 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.85 | $23.99 | +0.6% | +0.5% | +1.1% | -0.4% | +0.4% | +0.3% |
| Jun 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.55 | $23.54 | -0.0% | -0.2% | -0.2% | +0.6% | +1.1% | +0.5% |
| Mar 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $24.84 | $24.84 | +0.0% | -2.1% | -0.7% | +0.2% | -2.4% | +0.1% |
| Oct 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.17 | $26.24 | +0.3% | +0.5% | -0.1% | -0.4% | -0.3% | +0.2% |
| Sep 8 | Aegis Capital | Maintains | Buy → Buy | — | $26.50 | $26.43 | -0.3% | -0.9% | +0.8% | -0.1% | +1.2% | -0.1% |
| Sep 6 | Wedbush | Downgrade | Outperform → Neutral | — | — | — | — | — | — | — | — | — |
| Jun 29 | Aegis Capital | Maintains | Buy → Buy | — | $25.15 | $25.17 | +0.1% | +0.1% | +0.5% | -0.9% | -0.1% | +0.4% |
| Sep 4 | Wedbush | Upgrade | Neutral → Outperform | — | — | — | — | — | — | — | — | — |
| Jun 12 | H.C. Wainwright | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Mar 27 | Wedbush | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Nov 13 | Wedbush | Downgrade | Outperform → Neutral | — | — | — | — | — | — | — | — | — |
| Jul 22 | Jefferies | Downgrade | Buy → Hold | — | — | — | — | — | — | — | — | — |
| Jun 28 | Susquehanna | Downgrade | Positive → Neutral | — | — | — | — | — | — | — | — | — |
| Mar 11 | Ladenburg Thalmann | Upgrade | Neutral → Buy | — | — | — | — | — | — | — | — | — |
| Nov 9 | Ladenburg Thalmann | Downgrade | Buy → Neutral | — | — | — | — | — | — | — | — | — |
| Apr 28 | McNicoll Lewis Vlak | Upgrade | Hold → Buy | — | — | — | — | — | — | — | — | — |
| Mar 10 | McNicoll Lewis Vlak | Downgrade | Buy → Hold | — | — | — | — | — | — | — | — | — |
| Mar 4 | Ladenburg Thalmann | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Mar 4 | Credit Suisse | Downgrade | Outperform → Neutral | — | — | — | — | — | — | — | — | — |
| May 8 | Canaccord Genuity | Upgrade | Hold → Buy | — | — | — | — | — | — | — | — | — |
| Jan 6 | Wedbush | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| May 8 | Ladenburg Thalmann | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Mar 19 | Ladenburg Thalmann | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
No insider trades available.
No recent filings available.
Data updated apr 27, 2026 10:41am
· Source: massive.com